|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02656 160 HEALTH
Nominal 
8.555 -0.345 (-3.876%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 318,750 | 9.663% | 651,868 | 620,682 | 628,606 | 525,646 |
| Cost of Sales | (233,378) | 2.978% | (481,710) | (460,495) | (491,279) | (407,359) |
| Gross Profit | 85,372 | 33.319% | 170,158 | 160,187 | 137,327 | 118,287 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (591) | -83.966% | (10,219) | (8,284) | (7,333) | (1,022) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 1,534 | -- | (77,331) | (106,956) | (110,676) | (118,957) | |
| Taxation | 142 | -- | 2,798 | (1,290) | (547) | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | 5,024 | (1,108) | |
| Non-controlling Interests | 461 | -9.608% | 1,547 | 559 | (2,617) | 8,760 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 2,137 | -- | (72,986) | (107,687) | (108,816) | (111,305) | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 4,000 | 239.559% | 2,887 | 2,330 | 11,156 | 39,773 |
| Depreciation & Amortisation | 3,367 | -27.090% | 6,496 | 10,826 | 11,631 | 11,245 |
| Directors' Emoluments | -- | -- | 16,516 | 24,392 | 18,600 | 2,775 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | 0.700 | -- | -24.000 | -37.000 | -- | -- |
| DPS (cts) | 0.000 | -- | 0.000 | -- | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.377) | (0.191) | -- | -- |
| NBV per share ($) | 0.711 | -- | 0.710 | -- | -- | -- |
| Remarks: | Real time quote last updated: 11/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 2,137 |
| %Change | -- |
| EPS / (LPS) | RMB 0.007 |
| NBV Per Share (¥) | RMB 0.711 |